Chad Seaver is Chief Executive Officer and Board Manager of Cintilight. He is a fervent leader of med- and bio-tech with over twenty-five years’ experience leading vanguard teams and striking creative deals. He was most recently co-founder, CEO, and Board Director of neurosurgical startup Arkis BioSciences, acquired in 2019 by Integra LifeSciences. Dr. Seaver previously held various senior management positions with Siemens Healthcare. Most prominently, he led development and commercialization of the company’s first time‐of‐flight positron emission tomography (PET) scanner, introduced as the Biograph mCT at the 2008 EANM.

Ron Grazioso is Chief Technology Officer for Cintilight, having worked in radiation and detector physics for over twenty years. He obtained a B.S. in Mechanical and Nuclear Engineering from Worcester Polytechnic Institute and an M.S. in Nuclear Engineering from the University of New Mexico. During his graduate studies, Mr. Grazioso worked at the Kyoto University Research Reactor Institute in Japan and at Los Alamos National Laboratory. After graduating, he was employed as a research scientist for Radiation Monitoring Devices (RMD) in Watertown, Massachusetts.

Philipp Braeuninger-Weimer is co-founder and Chief Scientific Officer of Cintilight. His experience spans building and leading teams of international experts that translate early scientific ideas into products. Prior to joining Cintilight, he was the Scientific Lead for the Deep Science Fund at Intellectual Ventures where he initiated and led several highly successful projects that created breakthrough products in the field of Materials and Physics.

Dr. Braeuninger-Weimer received his Ph.D. in Engineering from the Center of Advanced Photonics and Electronics at the University of Cambridge.